| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06045754 | A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in… | Crohn's Disease | Recruiting |
| NCT06180382 | Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease… | Crohn's Disease | Recruiting |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT06100744 | A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves… | Juvenile Psoriatic Arthritis | Recruiting |
| NCT05814627 | Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib… | Rheumatoid Arthritis | Active, Not Recruiting |
| NCT04527380 | A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis… | Juvenile Psoriatic Arthritis | Active, Not Recruiting |
| NCT04088409 | A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old… | Uveitis | Active, Not Recruiting |
| NCT06640517 | Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in… | Plaque Psoriasis | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05535738 | Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation | Skin Inflammation | Active, Not Recruiting |
| Phase 2 | |||
| NCT06941376 | An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With… | Relapsing Polychondritis | Recruiting |
| NCT06037811 | Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory… | Inflammatory Arthritis | Recruiting |
| NCT07151937 | A Study of LAD191 in Adults With Hidradenitis Suppurativa | Hidradenitis Suppurativa | Recruiting |
| NCT06996652 | An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent… | REM Sleep Behavior Disorder | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07061574 | A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent… | Type 1 Diabetes | Recruiting |
| Not specified | |||
| NCT07491913 | Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission | Takayasu Arteritis | Recruiting |
| NCT07398651 | Apremilast and Adalimumab in Psoriatic Arthritis Patients | Psoriatic Arthritis | Not Yet Recruiting |
| NCT06016517 | Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis | Arthritis, Rheumatoid | Not Yet Recruiting |